Guidance extended from year-end 2027 to early 2028, with operating expense reduction targets reiterated and achieved at a greater scale (now 35% year-over-year, 10% below guidance). Strategic focus ...
Recursion Pharmaceuticals (RXRX) stock surged after the company significantly beat Street forecasts with its Q4 2025 results.
Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the ...
One of the grand challenges of artificial intelligence is developing agents capable of conducting scientific research and discovering new knowledge. While frontier models have already been used to aid ...
Abstract: Recently, the operational domain of unmanned aerial vehicles (UAVs) has expanded from outdoor environments to indoor spaces such as factories, power plants, and tunnels. In these ...
Abstract: For vertical Bell Laboratories layered space-time architecture (V-BLAST), the original fast recursive algorithm was proposed, and then several improvements were proposed successively to ...